Article info

Download PDFPDF

COPD and drugs: new and old concepts
P254 NVA237 once daily improves exercise endurance in patients with COPD from the first dose: the GLOW3 trial
Free

Citation

Singh D, Beeh K, Drollmann A, et al
P254 NVA237 once daily improves exercise endurance in patients with COPD from the first dose: the GLOW3 trial

Publication history

  • First published December 2, 2011.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.